Literature DB >> 27730821

Spectrum of biliary abnormalities in portal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHPVO)-a prospective magnetic resonance cholangiopancreaticography (MRCP) based study.

Shumyla Jabeen1, Irfan Robbani1, Naseer A Choh1, Obaid Ashraf1, Feroze Shaheen1, Tariq Gojwari1, Sabeeha Gul2.   

Abstract

OBJECTIVE: To characterize biliary abnormalities seen in portal cavernoma cholangiopathy (PCC) on MR cholangiopancreaticography (MRCP) and elucidate certain salient features of the disease by collaborating our findings with those of previous studies.
METHODS: We prospectively enrolled 52 patients with portal cavernoma secondary to idiopathic extrahepatic portal vein obstruction, who underwent a standard MRCP protocol. Images were analyzed for abnormalities involving the entire biliary tree. Terms used were those proposed by the Indian National Association for Study of the Liver. Angulation of the common bile duct (CBD) was measured in all patients with cholangiopathy.
RESULTS: Cholangiopathy was seen in 80.7% of patients on MRCP. Extrahepatic ducts were involved in 95% of patients either alone (26%) or in combination with the intrahepatic ducts (69%). Isolated involvement of the intrahepatic ducts was seen in 4.8% of patients. Abnormalities of the extrahepatic ducts included angulation (90%), scalloping (76.2%), extrinsic impression/indentation (45.2%), stricture (14.3%) and smooth dilatation (4.8%). The mean CBD angle was 113.2 ± 19.8°. Abnormalities of the intrahepatic ducts included smooth dilatation (40%), irregularity (28%) and narrowing (9%). Cholelithiasis, choledocholithiasis and hepatolithiasis were seen in 28.6% (12) patients, 14.3% (6) patients and 11.9% (5) patients, respectively. There was a significant association between choledocholithiasis and CBD stricture, with no significant association between choledocholithiasis and cholelithiasis. A significant association was also seen between hepatolithiasis and choledocholithiasis.
CONCLUSION: The spectrum of biliary abnormalities in PCC has been explored and some salient features of the disease have been elucidated, which allow a confident diagnosis of this entity. Advances in knowledge: PCC preferentially involves the extrahepatic biliary tree. Changes in the intrahepatic ducts generally occur as sequelae of involvement of the extrahepatic ducts, although isolated involvement of the intrahepatic ducts does occur. Increased angulation of the CBD and scalloping are most commonly seen. Angulation may predispose to choledocholithiasis and thus development of symptomatic cholangiopathy. Choledocholithiasis and hepatolithiasis occur as sequelae of PCC.

Entities:  

Mesh:

Year:  2016        PMID: 27730821      PMCID: PMC5604928          DOI: 10.1259/bjr.20160636

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  32 in total

1.  Portal cholangiopathy: radiological classification and natural history.

Authors:  Elba Llop; Carmen de Juan; Susana Seijo; Angeles García-Criado; Juan G Abraldes; Jaume Bosch; Juan Carlos García-Pagán
Journal:  Gut       Date:  2011-01-26       Impact factor: 23.059

Review 2.  Biliary tract anatomy and its relationship with venous drainage.

Authors:  Chittapuram S Ramesh Babu; Malay Sharma
Journal:  J Clin Exp Hepatol       Date:  2013-05-25

Review 3.  How can portal vein cavernous transformation cause chronic incomplete biliary obstruction?

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

4.  Association between cholangiographic angulation of the common bile duct and choledocholithiasis.

Authors:  B L Warren
Journal:  S Afr J Surg       Date:  1987-03       Impact factor: 0.375

5.  An angulated common bile duct predisposes to recurrent symptomatic bile duct stones after endoscopic stone extraction.

Authors:  D Keizman; M I Shalom; F M Konikoff
Journal:  Surg Endosc       Date:  2006-07-20       Impact factor: 4.584

Review 6.  Portal ductopathy: clinical importance and nomenclature.

Authors:  Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

Review 7.  Ischemic cholangiopathy.

Authors:  Pierre Deltenre; Dominique-Charles Valla
Journal:  Semin Liver Dis       Date:  2008-09-23       Impact factor: 6.115

8.  Pseudosclerosing cholangitis in extrahepatic portal venous obstruction.

Authors:  J B Dilawari; Y K Chawla
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 9.  Pathogenesis of Portal Cavernoma Cholangiopathy: Is it Compression by Collaterals or Ischemic Injury to Bile Ducts During Portal Vein Thrombosis?

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2014-01-02

10.  Gallstone formation in dogs after selective occlusion of the portal vein branches.

Authors:  T Eto
Journal:  Jpn J Surg       Date:  1988-05
View more
  4 in total

Review 1.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

2.  Benign Hepatic Nodules in Patients With Primary Extrahepatic Portal Vein Obstruction: Clinical and Magnetic Resonance Imaging Features.

Authors:  Kapil Semalti; Ragini Kilambi; Sujoy Pal; Deep N Srivastava; Peush Sahni; Kumble S Madhusudhan
Journal:  J Clin Exp Hepatol       Date:  2022-04-20

3.  Changes in liver morphology in patients with extrahepatic portal venous obstruction: a retrospective magnetic resonance imaging study.

Authors:  Pankaj Gupta; Naveen Kalra; Ajay Gulati; Karamvir Chandel; Prashant Priyaranjan; Prajwal Dahal; Saroj K Sinha; Ajay Duseja; Radha K Dhiman; Manavjit Singh Sandhu
Journal:  Br J Radiol       Date:  2019-04-09       Impact factor: 3.039

4.  Portal Cavernoma Cholangiopathy in Children: An Evaluation Using Magnetic Resonance Cholangiography and Endoscopic Ultrasound.

Authors:  Vybhav Venkatesh; Surinder S Rana; Anmol Bhatia; Sadhna B Lal
Journal:  J Clin Exp Hepatol       Date:  2021-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.